Literature DB >> 6702746

"Monocytoid" cells in reactive follicular hyperplasia with and without multifocal histiocytic reactions: an immunohistochemical study of 21 cases including suspected cases of toxoplasmic lymphadenitis.

K Sheibani, R M Fritz, C D Winberg, J S Burke, H Rappaport.   

Abstract

The presence of "monocytoid" cells in toxoplasmic lymphadenitis is a distinctive histopathologic finding, but the exact nature and immunologic properties of these cells have not been characterized clearly. The authors have evaluated the immunohistochemical features of monocytoid cells in fresh-frozen and paraffin-embedded, fixed lymph node material from 21 cases of reactive follicular hyperplasia including suspected cases of toxoplasmic lymphadenitis. This study revealed that monocytoid cells contain (1) the B lymphocyte surface membrane differentiation antigens B-1 and BA-1, and (2) surface membrane-associated immunoglobulin light chains in a polyclonal distribution. No positive reaction was observed when monocytoid cells were studied with monoclonal antibodies specific for peripheral T cells or with antibodies considered to be specific for cells of the monocytic/histiocytic cell line. The results indicate that monocytoid cells, despite their distinct morphologic appearance, have surface marker characteristics of polyclonal B lymphocytes. Therefore, "monocytoid B lymphocytes" would be a more appropriate designation for these cells.

Entities:  

Mesh:

Year:  1984        PMID: 6702746     DOI: 10.1093/ajcp/81.4.453

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

Review 1.  [Diagnostic spectrum of reactive lymph node changes].

Authors:  S Hartmann; S Kriener; M L Hansmann
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

2.  Monocytoid B cell lymphoma.

Authors:  S S Banerjee; M Harris; B P Eyden; J A Radford; C J Harrison; A R Mainwaring
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

3.  Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency.

Authors:  Susanne Unger; Maximilian Seidl; Annette Schmitt-Graeff; Joachim Böhm; Klaudia Schrenk; Claudia Wehr; Sigune Goldacker; Ruth Dräger; Barbara C Gärtner; Paul Fisch; Martin Werner; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2014-05-02       Impact factor: 8.317

4.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.

Authors:  D Emilie; M Peuchmaur; M C Maillot; M C Crevon; N Brousse; J F Delfraissy; J Dormont; P Galanaud
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes.

Authors:  J J van den Oord; C de Wolf-Peeters; R De Vos; V J Desmet
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

6.  Monocytoid B cell lymphoma: clinical and prognostic features of 21 patients.

Authors:  S B Cogliatti; K Lennert; M L Hansmann; T L Zwingers
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

7.  Immunoreactivity of neoplastic and non-neoplastic monocytoid B lymphocytes for DBA.44 and other antibodies.

Authors:  M Ohsawa; H Kanno; T Machii; K Aozasa
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

8.  Monocytoid B-cells occurring in Hodgkin's disease.

Authors:  L Plank; M L Hansmann; R Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Immunohistological diagnosis of "plasmacytoid T cell lymphoma" in paraffin wax sections.

Authors:  J O Thomas; K Beiske; I Hann; C Koo; D Y Mason
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

10.  Monocytoid B-cell lymphoma. A novel B-cell neoplasm.

Authors:  K Sheibani; C C Sohn; J S Burke; C D Winberg; A M Wu; H Rappaport
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.